Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma

Autor: Vajavaara, Heli, Mortensen, Julie Bondgaard, Leivonen, Suvi-Katri, Hansen, Ida Monrad, Ludvigsen, Maja, Holte, Harald, Jørgensen, Judit, Bjerre, Mette, d’Amore, Francesco, Leppä, Sirpa

Publikováno v: Cancers
Volume 13
Issue 3
Vajavaara, H, Mortensen, J B, Leivonen, S-K, Hansen, I M, Ludvigsen, M, Holte, H, Jørgensen, J, Bjerre, M, d'Amore, F & Leppä, S 2021, ' Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma ', Cancers, vol. 13, no. 3, 398 . https://doi.org/10.3390/cancers13030398
Cancers, Vol 13, Iss 398, p 398 (2021)

Interaction of checkpoint receptor programmed death 1 (PD-1) with its ligand 1 (PD-L1) downregulates T cell effector functions and thereby leads to tumor immune escape. Here, we aimed to determine the clinical significance of soluble PD-1 (sPD-1) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5730612d44ee7fedf150fed09a6ebf9a

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.